Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent Developments - Forecast to 2030

January 2024 | 172 pages | ID: G91A43E76F4CEN
iGATE Research Pvt. Ltd.

Abstracts

The global narcolepsy drugs market was valued at US$ 3,596 Million in 2023, and is projected to reach US$ 6,138 Million by 2030. Narcolepsy is a chronic neurological disorder that affects the brain’s ability to regulate sleep-wake cycles, resulting in excessive daytime sleepiness (EDS) and, in many cases, cataplexy (sudden loss of muscle control). People suffering from narcolepsy frequently struggle to stay alert for extended periods and experience excessive sleepiness for most of the day. According to the National Institute of Neurological Disorders and Stroke (NINDS) estimates, narcolepsy affects over 3 million people globally and about 135,000 to 200,000 people in the United States. The growing stress levels among individuals, an upsurge in intake of alcohol, tobacco, and other dangerous addictive substances is likely to raise the number of patients with narcolepsy disorders.

Narcolepsy is a lifelong condition that cannot be cured, but medicines and lifestyle changes can help in managing the symptoms. Narcolepsy is currently treated with sodium oxybate, central nervous systems stimulants, selective serotonin reuptake inhibitors (SSRIs) and other antidepressants, but these therapeutics only provide symptomatic treatment. The global narcolepsy drugs market has witnessed significant growth in recent years owing to the rising prevalence of narcolepsy and increased awareness about the condition. The market is driven by the increasing demand for effective treatment options that can alleviate the narcolepsy symptoms and improve the quality of life for affected individuals. Pharmaceutical companies such as Jazz Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals, Axsome Therapeutics Inc., NLS Pharmaceutics and other companies are actively involved in research and development activities to introduce novel and more efficient drugs in the market. Moreover, governments in countries such as India, China, and South Africa are promoting the manufacturing of narcolepsy drugs due to the associated health benefits, which is projected to fuel the narcolepsy drugs market over the forecast period. The increasing awareness programs conducted by various organizations such as Wake Up Narcolepsy, the American Academy of Sleep Medicine, Narcolepsy UK, Narcolepsy Australia, and many others are increasing awareness levels about the disease and guiding people and healthcare professionals to improve the quality of life of patients with narcolepsy.

Recent Developments

• In July 2023, the U.S. FDA conducted a comprehensive review of NLS Pharmaceutics' research protocol, particularly focusing on the potential of Mazindol ER as a therapeutic solution for narcolepsy. This review is a part of the ongoing AMAZE program, highlighting the commitment to finding effective treatments for this condition.
• In May 2023, Avadel Pharmaceuticals received final U.S. FDA approval for its drug Lumryz, an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy.
• In March 2023, the European Medicines Agency has granted an extension of the indication for the marketing authorization for WAKIX (pitolisant), which is now indicated for the treatment of narcolepsy in children from the age of 6 years, with or without cataplexy.
• In January 2023, Hikma Pharmaceuticals PLC announced that it has launched an authorized generic version of Jazz Pharmaceuticals' Xyrem (sodium oxybate) oral solution CIII in the U.S.

By Therapeutic Type: Global Narcolepsy Drugs Market and Forecast - Key Takeaways

• Sodium oxybate segment dominates the global narcolepsy drugs market owing to its widespread usage in treating narcolepsy symptoms such as excessive daytime sleepiness and cataplexy. Sodium oxybate medications, such as Xyrem, have been widely prescribed and have demonstrated significant efficacy in managing these symptoms, leading to their dominant market position.
• Central nervous system stimulants held the second-largest share of the market in 2023. The increasing R&D activities related to CNS stimulants for patients with rare neurological diseases are expected to fuel segment growth.
• The tricyclic antidepressants segment is anticipated to demonstrate the highest growth over the forecast period.

By Disease Type: Global Narcolepsy Drugs Market and Forecast - Key Takeaways

• The excessive daytime sleepiness (EDS) segment dominates the global market for narcolepsy drugs in 2023. The demand for drugs that effectively manage excessive daytime sleepiness remains high, prompting ongoing research into improved treatment options.
• The cataplexia segment is projected to register highest growth over the forecast period, owing to the increasing adoption of novel drugs such as WAKIX and Xywav for the disease treatment. Cataplexy is one of the most dangerous symptoms associated with narcolepsy, characterized by a sudden loss of muscle tone often triggered by sudden, strong emotional experiences. Innovative treatment options targeting cataplexy are being developed to address this challenging symptom, fueling the segment’s growth.

By End User: Global Narcolepsy Drugs Market and Forecast - Key Takeaways

• The hospitals segment dominates the global market for narcolepsy drugs, owing to growing demand for specialized diagnostic services, sleep studies, and comprehensive care provided by hospital-based sleep centers.
• The diagnostics centers segment is projected to register highest growth over the forecast period owing to increased adoption of advanced technology, improved infrastructure, and substantial funding for these centers’ expansion.

By Region: Global Narcolepsy Drugs Market and Forecast - Key Takeaways

• North America dominated the global narcolepsy drugs market in 2023, and will continue to maintain its dominance over the forecast period, owing to increasing prevalence of narcoleptic disorders, advanced healthcare system, growing investments in research and development, rising awareness levels pertaining to diagnosis & associated treatments, and the introduction of novel therapeutic products.
• Europe is the second largest market for narcolepsy drugs, driven by the high discretionary income and growing consciousness regarding the advantages of narcolepsy drugs in the European countries.
• Asia Pacific is likely to witness fastest growth over the forecast period, owing to presence of large patient pool suffering from narcolepsy diseases, rising awareness among people, growing investments in pharmaceutical & biotechnology sectors, and supportive government initiatives.
• Latin America and Middle East & Africa are competing closely to grab maximum share of the global narcolepsy drugs market.

iGATE RESEARCH report titled “Global Narcolepsy Drugs Market, By Therapeutic Type (Central Nervous Systems Stimulants, Selective Serotonin Reuptake Inhibitors, Sodium Oxybate, Tricyclic Antidepressants, Others), By Disease Type (Excessive Daytime Sleepiness, Cataplexia, Other Disease Type), By End User, Regional Analysis, Pipeline Analysis, Key Company Profiles, Financial Insights, Trends and Recent Developments - Forecast to 2030” provides a comprehensive analysis of the Global Narcolepsy Drugs Market.

This 172 Pages report with 95 Figures and 12 Tables has been analyzed from 10 View Points:

1) Global Narcolepsy Drugs Market and Forecast (2018 - 2030)

2) Global Narcolepsy Drugs Market Share and Forecast (2018 - 2030)

3) By Therapeutic Type - Global Narcolepsy Drugs Market and Forecast (2018 - 2030)

4) By Disease Type - Global Narcolepsy Drugs Market and Forecast (2018 - 2030)

5) By End User - Global Narcolepsy Drugs Market and Forecast (2018 - 2030)

6) By Region - Global Narcolepsy Drugs Market and Forecast (2018 - 2030)

7) Global Narcolepsy Drugs Market - Recent Developments

8) Global Narcolepsy Drugs Market - Pipeline Analysis

9) Global Narcolepsy Drugs Market - Company Profiles, Financials, Recent Developments

10) Global Narcolepsy Drugs Market Dynamics - SWOT Analysis, Growth Drivers & Challenges

By Therapeutic Type - Global Narcolepsy Drugs Market & Forecast

• Central Nervous Systems Stimulants
• Selective Serotonin Reuptake Inhibitor
• Sodium Oxybate
• Tricyclic Antidepressants
• Other Therapeutic Type

By Disease Type - Global Narcolepsy Drugs Market and Forecast

• Daytime Extreme Sleepiness
• Cataplexia
• Other Disease Types

By End User - Global Narcolepsy Drugs Market & Forecast

• Hospitals
• Diagnostics Centers
• Others

By Region - Global Narcolepsy Drugs Market & Forecast

1. North America

• United States
• Canada

2. Europe

• Germany
• France
• United Kingdom
• Italy
• Spain
• Switzerland
• Netherlands
• Belgium
• Rest of Europe

3. Asia Pacific

• Japan
• China
• South Korea
• India
• Australia
• Rest of Asia Pacific

4. Latin America

• Brazil
• Mexico
• Rest of South America

5. Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Egypt
• Rest of Middle East & Africa

Global Narcolepsy Drugs Market - Key Company Profiles, Recent Developments, Financial Insights

1. Jazz Pharmaceuticals Plc

2. Teva Pharmaceutical Industries Limited

3. Novartis AG

4. Ligand Pharmaceuticals Inc.

5. Hikma Pharmaceuticals Plc

6. Takeda Pharmaceutical Company Limited

7. Johnson & Johnson

8. Harmony Biosciences Holdings Inc.

9. Axsome Therapeutics Inc.

10. Avadel Pharmaceuticals plc

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Contents

1. INTRODUCTION

1.1 Industry Definition and Research Scope
1.2 Research Methodology

2. EXECUTIVE SUMMARY


3. GLOBAL NARCOLEPSY DRUGS MARKET AND FORECAST (2018 - 2030)


4. GLOBAL NARCOLEPSY DRUGS MARKET SHARE AND FORECAST (2018 - 2030)

4.1 By Therapeutic Type - Global Narcolepsy Drugs Market Share and Forecast
4.2 By Disease Type - Global Narcolepsy Drugs Market Share and Forecast
4.3 By End Users - Global Narcolepsy Drugs Market Share and Forecast
4.4 By Region - Global Narcolepsy Drugs Market Share and Forecast

5. BY THERAPEUTIC TYPE - GLOBAL NARCOLEPSY DRUGS MARKET AND FORECAST (2018 - 2030)

5.1 Therapeutic Type - Global Central Nervous Systems Stimulants Market and Forecast
5.2 Therapeutic Type - Global Selective Serotonin Reuptake Inhibitors Market and Forecast
5.3 Therapeutic Type - Global Sodium Oxybate Market and Forecast
5.4 Therapeutic Type - Global Tricyclic Antidepressants Market and Forecast
5.5 Therapeutic Type - Global Other Therapeutic Type Market and Forecast

6. BY DISEASE TYPE - GLOBAL NARCOLEPSY DRUGS MARKET AND FORECAST (2018 - 2030)

6.1 Disease Type - Global Excessive Daytime Sleepiness Market and Forecast
6.2 Disease Type - Global Cataplexia Market and Forecast
6.3 Disease Type - Global Other Disease Type Market and Forecast

7. BY END USER - GLOBAL NARCOLEPSY DRUGS MARKET AND FORECAST (2018 - 2030)

7.1 Global Narcolepsy Drugs Market - Diagnostics Centers Market and Forecast
7.2 Global Narcolepsy Drugs Market - Hospitals Market and Forecast
7.3 Global Narcolepsy Drugs Market - Others Market and Forecast

8. BY REGION - GLOBAL NARCOLEPSY DRUGS MARKET AND FORECAST (2018 - 2030)

8.1 Market Summary - By Region
8.2 North America - Narcolepsy Drugs Market and Forecast
  8.2.1 United States - Narcolepsy Drugs Market and Forecast
  8.2.2 Canada - Narcolepsy Drugs Market and Forecast
8.3 Europe - Narcolepsy Drugs Market and Forecast
  8.3.1 Germany - Narcolepsy Drugs Market and Forecast
  8.3.2 France - Narcolepsy Drugs Market and Forecast
  8.3.3 United Kingdom - Narcolepsy Drugs Market and Forecast
  8.3.4 Italy - Narcolepsy Drugs Market and Forecast
  8.3.5 Spain - Narcolepsy Drugs Market and Forecast
  8.3.6 Switzerland - Narcolepsy Drugs Market and Forecast
  8.3.7 Netherlands - Narcolepsy Drugs Market and Forecast
  8.3.8 Belgium - Narcolepsy Drugs Market and Forecast
  8.3.9 Rest of Europe - Narcolepsy Drugs Market and Forecast
8.4 Asia Pacific - Narcolepsy Drugs Market and Forecast
  8.4.1 Japan - Narcolepsy Drugs Market and Forecast
  8.4.2 China - Narcolepsy Drugs Market and Forecast
  8.4.3 South Korea - Narcolepsy Drugs Market and Forecast
  8.4.4 India - Narcolepsy Drugs Market and Forecast
  8.4.5 Australia - Narcolepsy Drugs Market and Forecast
  8.4.6 Rest of Asia Pacific - Narcolepsy Drugs Market and Forecast
8.5 Latin America - Narcolepsy Drugs Market and Forecast
  8.5.1 Brazil - Narcolepsy Drugs Market and Forecast
  8.5.2 Mexico - Narcolepsy Drugs Market and Forecast
  8.5.3 Rest of Latin America - Narcolepsy Drugs Market and Forecast
8.6 Middle East & Africa - Narcolepsy Drugs Market and Forecast
  8.6.1 United Arab Emirates - Narcolepsy Drugs Market and Forecast
  8.6.2 Saudi Arabia - Narcolepsy Drugs Market and Forecast
  8.6.3 Israel - Narcolepsy Drugs Market and Forecast
  8.6.4 South Africa - Narcolepsy Drugs Market and Forecast
  8.6.5 Egypt - Narcolepsy Drugs Market and Forecast
  8.6.6 Rest of Middle East & Africa - Narcolepsy Drugs Market and Forecast

9. GLOBAL NARCOLEPSY DRUGS MARKET - RECENT DEVELOPMENTS


10. GLOBAL NARCOLEPSY DRUGS MARKET - PIPELINE ANALYSIS


11. GLOBAL NARCOLEPSY DRUGS MARKET - COMPANY PROFILES

11.1 Jazz Pharmaceuticals Plc
  11.1.1 Company Overview
  11.1.2 Recent Developments
11.2 Teva Pharmaceutical Industries Limited
  11.2.1 Company Overview
11.3 Novartis AG
  11.3.1 Company Overview
11.4 Ligand Pharmaceuticals Inc.
  11.4.1 Company Overview
  11.4.2 Recent Developments
11.5 Hikma Pharmaceuticals Plc
  11.5.1 Company Overview
  11.5.2 Recent Developments
11.6 Takeda Pharmaceutical Company Limited
  11.6.1 Company Overview
  11.6.2 Recent Developments
11.7 Johnson & Johnson
  11.7.1 Company Overview
11.8 Harmony Biosciences Holdings Inc.
  11.8.1 Company Overview
  11.8.2 Recent Developments
11.9 Axsome Therapeutics Inc.
  11.9.1 Company Overview
  11.9.2 Recent Developments
11.10 Avadel Pharmaceuticals plc
  11.10.1 Company Overview
  11.10.2 Recent Developments

12. GLOBAL NARCOLEPSY DRUGS - MARKET DYNAMICS

12.1 Global Narcolepsy Drugs Market - SWOT Analysis
12.2 Global Narcolepsy Drugs Market - Growth Drivers
12.3 Global Narcolepsy Drugs Market - Challenges

List Of Figures

LIST OF FIGURES:

Figure 3-1: Global - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 3-2: Global - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 5-1: Therapeutic Type - Global Central Nervous Systems Stimulants Market (Million US$), 2018 - 2023
Figure 5-2: Therapeutic Type - Forecast for Global Central Nervous Systems Stimulants Market (Million US$), 2024 - 2030
Figure 5-3: Therapeutic Type - Global Selective Serotonin Reuptake Inhibitors Market (Million US$), 2018 - 2023
Figure 5-4: Therapeutic Type - Forecast for Global Selective Serotonin Reuptake Inhibitors Market (Million US$), 2024 - 2030
Figure 5-5: Therapeutic Type - Global Sodium Oxybate Market (Million US$), 2018 - 2023
Figure 5-6: Therapeutic Type - Forecast for Global Sodium Oxybate Market (Million US$), 2024 - 2030
Figure 5-7: Therapeutic Type - Global Tricyclic Antidepressants Market (Million US$), 2018 - 2023
Figure 5-8: Therapeutic Type - Forecast for Global Tricyclic Antidepressants Market (Million US$), 2024 - 2030
Figure 5-9: Therapeutic Type - Global Other Therapeutic Type Market (Million US$), 2018 - 2023
Figure 5-10: Therapeutic Type - Forecast for Global Other Therapeutic Type Market (Million US$), 2024 - 2030
Figure 6-1: Disease Type - Global Excessive Daytime Sleepiness Market (Million US$), 2018 - 2023
Figure 6-2: Disease Type - Forecast for Global Excessive Daytime Sleepiness Market (Million US$), 2024 - 2030
Figure 6-3: Disease Type - Global Cataplexia Market (Million US$), 2018 - 2023
Figure 6-4: Disease Type - Forecast for Global Cataplexia Market (Million US$), 2024 - 2030
Figure 6-5: Disease Type - Global Other Disease Type Market (Million US$), 2018 - 2023
Figure 6-6: Disease Type - Forecast for Global Other Disease Type Market (Million US$), 2024 - 2030
Figure 7-1: Global Narcolepsy Drugs - Diagnostics Centers Market (Million US$), 2018 - 2023
Figure 7-2: Global Narcolepsy Drugs - Forecast for Diagnostics Centers Market (Million US$), 2024 - 2030
Figure 7-3: Global Narcolepsy Drugs - Hospitals Market (Million US$), 2018 - 2023
Figure 7-4: Global Narcolepsy Drugs - Forecast for Hospitals Market (Million US$), 2024 - 2030
Figure 7-5: Global Narcolepsy Drugs - Others Market (Million US$), 2018 - 2023
Figure 7-6: Global Narcolepsy Drugs - Forecast for Others Market (Million US$), 2024 - 2030
Figure 8-1: Market Summary - By Region, 2023 - 2030
Figure 8-2: North America - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-3: North America - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-4: United States - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-5: United States - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-6: Canada - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-7: Canada - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-8: Europe - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-9: Europe - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-10: Germany - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-11: Germany - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-12: France - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-13: France - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-14: United Kingdom - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-15: United Kingdom - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-16: Italy - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-17: Italy - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-18: Spain - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-19: Spain - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-20: Switzerland - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-21: Switzerland - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-22: Netherlands - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-23: Netherlands - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-24: Belgium - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-25: Belgium - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-26: Rest of Europe - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-27: Rest of Europe - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-28: Asia Pacific - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-29: Asia Pacific - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-30: Japan - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-31: Japan - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-32: China - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-33: China - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-34: South Korea - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-35: South Korea - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-36: India - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-37: India - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-38: Australia - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-39: Australia - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-40: Rest of Asia Pacific - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-41: Rest of Asia Pacific - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-42: Latin America - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-43: Latin America - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-44: Brazil - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-45: Brazil - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-46: Mexico - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-47: Mexico - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-48: Rest of Latin America - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-49: Rest of Latin America - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-50: Middle East & Africa - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-51: Middle East & Africa - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-52: United Arab Emirates - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-53: United Arab Emirates - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-54: Saudi Arabia - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-55: Saudi Arabia - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-56: Israel - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-57: Israel - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-58: South Africa - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-59: South Africa - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-60: Egypt - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-61: Egypt - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 8-62: Rest of Middle East & Africa - Narcolepsy Drugs Market (Million US$), 2018 - 2023
Figure 8-63: Rest of Middle East & Africa - Forecast for Narcolepsy Drugs Market (Million US$), 2024 - 2030
Figure 11-1: Jazz Pharmaceuticals - Global Revenue (Million US$), 2018 - 2023e
Figure 11-2: Teva Pharmaceutical - Global Revenue (Million US$), 2018 - 2023e
Figure 11-3: Novartis AG - Global Revenue (Million US$), 2018 - 2023e
Figure 11-4: Ligand Pharmaceuticals Inc. - Global Revenue (Million US$), 2018 - 2023e
Figure 11-5: Hikma Pharmaceuticals Plc - Global Revenue (Million US$), 2018 - 2023e
Figure 11-6: Takeda Pharmaceutical - Global Revenue (Million US$), 2018 - 2023e
Figure 11-7: Johnson & Johnson - Global Revenue (Million US$), 2018 - 2023e
Figure 11-8: Harmony Biosciences Holdings Inc. - Global Revenue (Million US$), 2019 - 2024e

List Of Tables

LIST OF TABLES:

Table 4-1: By Therapeutic Type - Global Narcolepsy Drugs Market Share (Percent), 2018 - 2023
Table 4-2: By Therapeutic Type - Forecast for Global Narcolepsy Drugs Market Share (Percent), 2024 - 2030
Table 4-3: By Disease Type - Global Narcolepsy Drugs Market Share (Percent), 2018 - 2023
Table 4-4: By Disease Type - Forecast for Global Narcolepsy Drugs Market Share (Percent), 2024 - 2030
Table 4-5: By End Users - Global Narcolepsy Drugs Market Share (Percent), 2018 - 2023
Table 4-6: By End Users - Forecast for Global Narcolepsy Drugs Market Share (Percent), 2024 - 2030
Table 4-7: By Region - Global Narcolepsy Drugs Market Share (Percent), 2018 - 2023
Table 4-8: By Region - Forecast for Global Narcolepsy Drugs Market Share (Percent), 2024 - 2030
Table 10-1: Global Narcolepsy Drugs - 12. List of Pipeline Candidates and Phase of Development
Table 10-2: Global Narcolepsy Drugs - 12. List of Pipeline Candidates and Phase of Development
Table 10-3: Global Narcolepsy Drugs - 12. List of Pipeline Candidates and Phase of Development
Table 10-4: Global Narcolepsy Drugs - 12. List of Pipeline Candidates and Phase of Development